The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/14881
StudyName: Eligibility Breast Neoplasms NCT02297438
Date of export from the portal: 02.07.2020
Date of Upload / last change: 03.05.2016
License: Creative Commons BY 4.0

----

Description: 
A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]; ODM derived from: https://clinicaltrials.gov/show/NCT02297438
